Asthma – Pipeline Review, H2 2016

Global Markets Direct’s, ‘Asthma – Pipeline Review, H2 2016’, provides an overview of the Asthma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Asthma and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Asthma

The report reviews pipeline therapeutics for Asthma by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Asthma therapeutics and enlists all their major and minor projects

The report assesses Asthma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Asthma

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Asthma

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Asthma – Companies Involved in Therapeutics Development

4D Pharma Plc

AB Science SA

AbbVie Inc

Abeome Corporation

Accolade Pharmaceuticals, LLC

Acorda Therapeutics, Inc.

Adamis Pharmaceuticals Corporation

Advinus Therapeutics Ltd

Afferent Pharmaceuticals, Inc.

ALK-Abello A/S

Allergopharma GmbH & Co. KG

Almirall, S.A.

Amakem NV

Amgen Inc.

AnaptysBio, Inc.

AnGes MG, Inc.

Antisense Therapeutics Limited

ARA Healthcare Pvt. Ltd.

Array BioPharma Inc.

ASIT biotech s.a.

Astellas Pharma Inc.

AstraZeneca Plc

Asubio Pharma Co., Ltd.

Aurigene Discovery Technologies Limited

Axikin Pharmaceuticals, Inc.

Bioncotech Therapeutics SL

Biotec Pharmacon ASA

Boehringer Ingelheim GmbH

CalciMedica, Inc.

Cellceutix Corporation

Cellular Biomedicine Group, Inc.

Celon Pharma Sp. z o.o.

Chiesi Farmaceutici SpA

Circassia Pharmaceuticals Plc

Cognosci, Inc.

CSL Limited

Cumberland Pharmaceuticals, Inc.

Cynata Therapeutics Limited

Daiichi Sankyo Company, Limited

F. Hoffmann-La Roche Ltd.

Foresee Pharmaceuticals, LLC

Fountain Biopharma Inc.

Genentech, Inc.

GlaxoSmithKline Plc

Griffin Discoveries BV

Han Wha Pharma Co., Ltd.

HitGen LTD

Hydra Biosciences, Inc.

iCeutica, Inc.

iCo Therapeutics Inc.

Immupharma Plc

Infinity Pharmaceuticals, Inc.

INOXIA Lifesciences GmbH

Intech Biopharm Ltd

Invion Limited

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Johnson & Johnson

Kissei Pharmaceutical Co., Ltd.

Kolltan Pharmaceuticals, Inc.

KPI Therapeutics, Inc.

Kyowa Hakko Kirin Co., Ltd.

Lead Discovery Center GmbH

LegoChem Biosciences, Inc

Ligand Pharmaceuticals, Inc.

Lpath, Inc.

Mabtech Limited

Marinomed Biotechnologie GmbH

MedImmune, LLC

Merck & Co., Inc.

Mitsubishi Tanabe Pharma Corporation

Mycenax Biotech Inc.

NAL Pharmaceuticals Ltd.

NeoPharm Co., Ltd.

Novartis AG

Omeros Corporation

Ono Pharmaceutical Co., Ltd.

OPKO Health, Inc.

Orbis Biosciences Inc

Orion Oyj

Oxagen Limited

Palatin Technologies, Inc.

Panacea Biotec Limited

Panmira Pharmaceuticals, LLC.

Paradigm Biopharmaceuticals Limited

Peptinnovate Ltd

Pfizer Inc.

PharmaLundensis AB

Pharmaxis Limited

Pieris Pharmaceuticals Inc

Pila Pharma AB

Polyphor Ltd.

Promedior, Inc.

Prommune, Inc.

Protectimmun GmbH

Prous Institute for Biomedical Research S.A.

Pulmagen Therapeutics LLP

Pulmokine, Inc.

Re-Pharm Limited

Regeneron Pharmaceuticals Inc

Respiratorius AB

ReveraGen BioPharma, Inc.

Rhizen Pharmaceuticals S.A.

Saje Pharma, LLC

Shire Plc

Spring Bank Pharmaceuticals, Inc.

Stallergenes Greer plc

Sterna biologicals Gmbh & Co KG

Sumitomo Dainippon Pharma Co., Ltd.

Sun Pharma Advanced Research Company Ltd.

Sunovion Pharmaceuticals Inc.

Swecure AB

Synermore Biologics Co Ltd

Synovo GmbH

Syntrix Biosystems, Inc.

TaiwanJ Pharmaceuticals Co., Ltd.

Takeda Pharmaceutical Company Limited

Teva Pharmaceutical Industries Ltd.

The International Biotechnology Center (IBC) Generium

Therabron Therapeutics, Inc.

Theravance Biopharma, Inc.

Tolerys SA

United BioPharma, Inc.

Vectura Group Plc

Verona Pharma Plc

WhanIn Pharmaceutical Co., Ltd.

Xencor, Inc.

Yungjin Pharm. Co., Ltd.

Zambon Company S.p.A.

Table of Contents

Table of Contents

Table of Contents 2

Introduction 9

Asthma Overview 10

Therapeutics Development 11

Asthma - Therapeutics under Development by Companies 13

Asthma - Therapeutics under Investigation by Universities/Institutes 25

Asthma - Pipeline Products Glance 27

Asthma - Products under Development by Companies 31

Asthma - Products under Investigation by Universities/Institutes 48

Asthma - Companies Involved in Therapeutics Development 50

Asthma - Therapeutics Assessment 178

Drug Profiles 215

Asthma - Dormant Projects 645

Asthma - Discontinued Products 682

Asthma - Product Development Milestones 691

Appendix 704

List of Tables

List of Tables

Number of Products under Development for Asthma, H2 2016 41

Number of Products under Development for Asthma – Comparative Analysis, H2 2016 42

Number of Products under Development by Companies, H2 2016 44

Number of Products under Development by Companies, H2 2016 (Contd..1) 45

Number of Products under Development by Companies, H2 2016 (Contd..2) 46

Number of Products under Development by Companies, H2 2016 (Contd..3) 47

Number of Products under Development by Companies, H2 2016 (Contd..4) 48

Number of Products under Development by Companies, H2 2016 (Contd..5) 49

Number of Products under Development by Companies, H2 2016 (Contd..6) 50

Number of Products under Development by Companies, H2 2016 (Contd..7) 51

Number of Products under Development by Companies, H2 2016 (Contd..8) 52

Number of Products under Development by Companies, H2 2016 (Contd..9) 53

Number of Products under Development by Companies, H2 2016 (Contd..10) 54

Number of Products under Investigation by Universities/Institutes, H2 2016 55

Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 56

Comparative Analysis by Late Stage Development, H2 2016 57

Comparative Analysis by Clinical Stage Development, H2 2016 58

Comparative Analysis by Early Stage Development, H2 2016 59

Comparative Analysis by Unknown Stage Development, H2 2016 60

Products under Development by Companies, H2 2016 61

Products under Development by Companies, H2 2016 (Contd..1) 62

Products under Development by Companies, H2 2016 (Contd..2) 63

Products under Development by Companies, H2 2016 (Contd..3) 64

Products under Development by Companies, H2 2016 (Contd..4) 65

Products under Development by Companies, H2 2016 (Contd..5) 66

Products under Development by Companies, H2 2016 (Contd..6) 67

Products under Development by Companies, H2 2016 (Contd..7) 68

Products under Development by Companies, H2 2016 (Contd..8) 69

Products under Development by Companies, H2 2016 (Contd..9) 70

Products under Development by Companies, H2 2016 (Contd..10) 71

Products under Development by Companies, H2 2016 (Contd..11) 72

Products under Development by Companies, H2 2016 (Contd..12) 73

Products under Development by Companies, H2 2016 (Contd..13) 74

Products under Development by Companies, H2 2016 (Contd..14) 75

Products under Development by Companies, H2 2016 (Contd..15) 76

Products under Development by Companies, H2 2016 (Contd..16) 77

Products under Investigation by Universities/Institutes, H2 2016 78

Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 79

Asthma – Pipeline by 4D Pharma Plc, H2 2016 80

Asthma – Pipeline by AB Science SA, H2 2016 81

Asthma – Pipeline by AbbVie Inc, H2 2016 82

Asthma – Pipeline by Abeome Corporation, H2 2016 83

Asthma – Pipeline by Accolade Pharmaceuticals, LLC, H2 2016 84

Asthma – Pipeline by Acorda Therapeutics, Inc., H2 2016 85

Asthma – Pipeline by Adamis Pharmaceuticals Corporation, H2 2016 86

Asthma – Pipeline by Advinus Therapeutics Ltd, H2 2016 87

Asthma – Pipeline by Afferent Pharmaceuticals, Inc., H2 2016 88

Asthma – Pipeline by ALK-Abello A/S, H2 2016 89

Asthma – Pipeline by Allergopharma GmbH & Co. KG, H2 2016 90

Asthma – Pipeline by Almirall, S.A., H2 2016 91

Asthma – Pipeline by Amakem NV, H2 2016 92

Asthma – Pipeline by Amgen Inc., H2 2016 93

Asthma – Pipeline by AnaptysBio, Inc., H2 2016 94

Asthma – Pipeline by AnGes MG, Inc., H2 2016 95

Asthma – Pipeline by Antisense Therapeutics Limited, H2 2016 96

Asthma – Pipeline by ARA Healthcare Pvt. Ltd., H2 2016 97

Asthma – Pipeline by Array BioPharma Inc., H2 2016 98

Asthma – Pipeline by ASIT biotech s.a., H2 2016 99

Asthma – Pipeline by Astellas Pharma Inc., H2 2016 100

Asthma – Pipeline by AstraZeneca Plc, H2 2016 101

Asthma – Pipeline by Asubio Pharma Co., Ltd., H2 2016 102

Asthma – Pipeline by Aurigene Discovery Technologies Limited, H2 2016 103

Asthma – Pipeline by Axikin Pharmaceuticals, Inc., H2 2016 104

Asthma – Pipeline by Bioncotech Therapeutics SL, H2 2016 105

Asthma – Pipeline by Biotec Pharmacon ASA, H2 2016 106

Asthma – Pipeline by Boehringer Ingelheim GmbH, H2 2016 107

Asthma – Pipeline by CalciMedica, Inc., H2 2016 108

Asthma – Pipeline by Cellceutix Corporation, H2 2016 109

Asthma – Pipeline by Cellular Biomedicine Group, Inc., H2 2016 110

Asthma – Pipeline by Celon Pharma Sp. z o.o., H2 2016 111

Asthma – Pipeline by Chiesi Farmaceutici SpA, H2 2016 112

Asthma – Pipeline by Circassia Pharmaceuticals Plc, H2 2016 113

Asthma – Pipeline by Cognosci, Inc., H2 2016 114

Asthma – Pipeline by CSL Limited, H2 2016 115

Asthma – Pipeline by Cumberland Pharmaceuticals, Inc., H2 2016 116

Asthma – Pipeline by Cynata Therapeutics Limited, H2 2016 117

Asthma – Pipeline by Daiichi Sankyo Company, Limited, H2 2016 118

Asthma – Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 119

Asthma – Pipeline by Foresee Pharmaceuticals, LLC, H2 2016 120

Asthma – Pipeline by Fountain Biopharma Inc., H2 2016 121

Asthma – Pipeline by Genentech, Inc., H2 2016 122

Asthma – Pipeline by GlaxoSmithKline Plc, H2 2016 123

Asthma – Pipeline by Griffin Discoveries BV, H2 2016 124

Asthma – Pipeline by Han Wha Pharma Co., Ltd., H2 2016 125

Asthma – Pipeline by HitGen LTD, H2 2016 126

Asthma – Pipeline by Hydra Biosciences, Inc., H2 2016 127

Asthma – Pipeline by iCeutica, Inc., H2 2016 128

Asthma – Pipeline by iCo Therapeutics Inc., H2 2016 129

Asthma – Pipeline by Immupharma Plc, H2 2016 130

Asthma – Pipeline by Infinity Pharmaceuticals, Inc., H2 2016 131

Asthma – Pipeline by INOXIA Lifesciences GmbH, H2 2016 132

Asthma – Pipeline by Intech Biopharm Ltd, H2 2016 133

Asthma – Pipeline by Invion Limited, H2 2016 134

Asthma – Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H2 2016 135

Asthma – Pipeline by Johnson & Johnson, H2 2016 136

Asthma – Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2016 137

Asthma – Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016 138

Asthma – Pipeline by KPI Therapeutics, Inc., H2 2016 139

Asthma – Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2016 140

Asthma – Pipeline by Lead Discovery Center GmbH, H2 2016 141

Asthma – Pipeline by LegoChem Biosciences, Inc, H2 2016 142

Asthma – Pipeline by Ligand Pharmaceuticals, Inc., H2 2016 143

Asthma – Pipeline by Lpath, Inc., H2 2016 144

Asthma – Pipeline by Mabtech Limited, H2 2016 145

Asthma – Pipeline by Marinomed Biotechnologie GmbH, H2 2016 146

Asthma – Pipeline by MedImmune, LLC, H2 2016 147

Asthma – Pipeline by Merck & Co., Inc., H2 2016 148

Asthma – Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2016 149

Asthma – Pipeline by Mycenax Biotech Inc., H2 2016 150

Asthma – Pipeline by NAL Pharmaceuticals Ltd., H2 2016 151

Asthma – Pipeline by NeoPharm Co., Ltd., H2 2016 152

Asthma – Pipeline by Novartis AG, H2 2016 153

Asthma – Pipeline by Omeros Corporation, H2 2016 154

Asthma – Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016 155

Asthma – Pipeline by OPKO Health, Inc., H2 2016 156

Asthma – Pipeline by Orbis Biosciences Inc, H2 2016 157

Asthma – Pipeline by Orion Oyj, H2 2016 158

Asthma – Pipeline by Oxagen Limited, H2 2016 159

Asthma – Pipeline by Palatin Technologies, Inc., H2 2016 160

Asthma – Pipeline by Panacea Biotec Limited, H2 2016 161

Asthma – Pipeline by Panmira Pharmaceuticals, LLC., H2 2016 162

Asthma – Pipeline by Paradigm Biopharmaceuticals Limited, H2 2016 163

Asthma – Pipeline by Peptinnovate Ltd, H2 2016 164

Asthma – Pipeline by Pfizer Inc., H2 2016 165

Asthma – Pipeline by PharmaLundensis AB, H2 2016 166

Asthma – Pipeline by Pharmaxis Limited, H2 2016 167

Asthma – Pipeline by Pieris Pharmaceuticals Inc, H2 2016 168

Asthma – Pipeline by Pila Pharma AB, H2 2016 169

Asthma – Pipeline by Polyphor Ltd., H2 2016 170

Asthma – Pipeline by Promedior, Inc., H2 2016 171

Asthma – Pipeline by Prommune, Inc., H2 2016 172

Asthma – Pipeline by Protectimmun GmbH, H2 2016 173

Asthma – Pipeline by Prous Institute for Biomedical Research S.A., H2 2016 174

Asthma – Pipeline by Pulmagen Therapeutics LLP, H2 2016 175

Asthma – Pipeline by Pulmokine, Inc., H2 2016 176

Asthma – Pipeline by Re-Pharm Limited, H2 2016 177

Asthma – Pipeline by Regeneron Pharmaceuticals Inc, H2 2016 178

Asthma – Pipeline by Respiratorius AB, H2 2016 179

Asthma – Pipeline by ReveraGen BioPharma, Inc., H2 2016 180

Asthma – Pipeline by Rhizen Pharmaceuticals S.A., H2 2016 181

Asthma – Pipeline by Saje Pharma, LLC, H2 2016 182

Asthma – Pipeline by Shire Plc, H2 2016 183

Asthma – Pipeline by Spring Bank Pharmaceuticals, Inc., H2 2016 184

Asthma – Pipeline by Stallergenes Greer plc, H2 2016 185

Asthma – Pipeline by sterna biologicals Gmbh & Co KG, H2 2016 186

Asthma – Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2016 187

Asthma – Pipeline by Sun Pharma Advanced Research Company Ltd., H2 2016 188

Asthma – Pipeline by Sunovion Pharmaceuticals Inc., H2 2016 189

Asthma – Pipeline by Swecure AB, H2 2016 190

Asthma – Pipeline by Synermore Biologics Co Ltd, H2 2016 191

Asthma – Pipeline by Synovo GmbH, H2 2016 192

Asthma – Pipeline by Syntrix Biosystems, Inc., H2 2016 193

Asthma – Pipeline by TaiwanJ Pharmaceuticals Co., Ltd., H2 2016 194

Asthma – Pipeline by Takeda Pharmaceutical Company Limited, H2 2016 195

Asthma – Pipeline by Teva Pharmaceutical Industries Ltd., H2 2016 196

Asthma – Pipeline by The International Biotechnology Center (IBC) Generium, H2 2016 197

Asthma – Pipeline by Therabron Therapeutics, Inc., H2 2016 198

Asthma – Pipeline by Theravance Biopharma, Inc., H2 2016 199

Asthma – Pipeline by Tolerys SA, H2 2016 200

Asthma – Pipeline by United BioPharma, Inc., H2 2016 201

Asthma – Pipeline by Vectura Group Plc, H2 2016 202

Asthma – Pipeline by Verona Pharma Plc, H2 2016 203

Asthma – Pipeline by WhanIn Pharmaceutical Co., Ltd., H2 2016 204

Asthma – Pipeline by Xencor, Inc., H2 2016 205

Asthma – Pipeline by Yungjin Pharm. Co., Ltd., H2 2016 206

Asthma – Pipeline by Zambon Company S.p.A., H2 2016 207

Assessment by Monotherapy Products, H2 2016 208

Assessment by Combination Products, H2 2016 209

Number of Products by Stage and Target, H2 2016 211

Number of Products by Stage and Mechanism of Action, H2 2016 223

Number of Products by Stage and Route of Administration, H2 2016 242

Number of Products by Stage and Molecule Type, H2 2016 244

Asthma – Dormant Projects, H2 2016 675

Asthma – Dormant Projects (Contd..1), H2 2016 676

Asthma – Dormant Projects (Contd..2), H2 2016 677

Asthma – Dormant Projects (Contd..3), H2 2016 678

Asthma – Dormant Projects (Contd..4), H2 2016 679

Asthma – Dormant Projects (Contd..5), H2 2016 680

Asthma – Dormant Projects (Contd..6), H2 2016 681

Asthma – Dormant Projects (Contd..7), H2 2016 682

Asthma – Dormant Projects (Contd..8), H2 2016 683

Asthma – Dormant Projects (Contd..9), H2 2016 684

Asthma – Dormant Projects (Contd..10), H2 2016 685

Asthma – Dormant Projects (Contd..11), H2 2016 686

Asthma – Dormant Projects (Contd..12), H2 2016 687

Asthma – Dormant Projects (Contd..13), H2 2016 688

Asthma – Dormant Projects (Contd..14), H2 2016 689

Asthma – Dormant Projects (Contd..15), H2 2016 690

Asthma – Dormant Projects (Contd..16), H2 2016 691

Asthma – Dormant Projects (Contd..17), H2 2016 692

Asthma – Dormant Projects (Contd..18), H2 2016 693

Asthma – Dormant Projects (Contd..19), H2 2016 694

Asthma – Dormant Projects (Contd..20), H2 2016 695

Asthma – Dormant Projects (Contd..21), H2 2016 696

Asthma – Dormant Projects (Contd..22), H2 2016 697

Asthma – Dormant Projects (Contd..23), H2 2016 698

Asthma – Dormant Projects (Contd..24), H2 2016 699

Asthma – Dormant Projects (Contd..25), H2 2016 700

Asthma – Dormant Projects (Contd..26), H2 2016 701

Asthma – Dormant Projects (Contd..27), H2 2016 702

Asthma – Dormant Projects (Contd..28), H2 2016 703

Asthma – Dormant Projects (Contd..29), H2 2016 704

Asthma – Dormant Projects (Contd..30), H2 2016 705

Asthma – Dormant Projects (Contd..31), H2 2016 706

Asthma – Dormant Projects (Contd..32), H2 2016 707

Asthma – Dormant Projects (Contd..33), H2 2016 708

Asthma – Dormant Projects (Contd..34), H2 2016 709

Asthma – Dormant Projects (Contd..35), H2 2016 710

Asthma – Dormant Projects (Contd..36), H2 2016 711

Asthma – Discontinued Products, H2 2016 712

Asthma – Discontinued Products (Contd..1), H2 2016 713

Asthma – Discontinued Products (Contd..2), H2 2016 714

Asthma – Discontinued Products (Contd..3), H2 2016 715

Asthma – Discontinued Products (Contd..4), H2 2016 716

Asthma – Discontinued Products (Contd..5), H2 2016 717

Asthma – Discontinued Products (Contd..6), H2 2016 718

Asthma – Discontinued Products (Contd..7), H2 2016 719

Asthma – Discontinued Products (Contd..8), H2 2016 720

List of Figures

List of Figures

Number of Products under Development for Asthma, H2 2016 41

Number of Products under Development for Asthma – Comparative Analysis, H2 2016 42

Number of Products under Development by Companies, H2 2016 43

Number of Products under Investigation by Universities/Institutes, H2 2016 55

Comparative Analysis by Late Stage Development, H2 2016 57

Comparative Analysis by Clinical Stage Development, H2 2016 58

Comparative Analysis by Early Stage Products, H2 2016 59

Assessment by Monotherapy Products, H2 2016 208

Assessment by Combination Products, H2 2016 209

Number of Products by Top 10 Targets, H2 2016 210

Number of Products by Stage and Top 10 Targets, H2 2016 210

Number of Products by Top 10 Mechanism of Actions, H2 2016 222

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 222

Number of Products by Top 10 Routes of Administration, H2 2016 241

Number of Products by Stage and Top 10 Routes of Administration, H2 2016 241

Number of Products by Top 10 Molecule Types, H2 2016 243

Number of Products by Stage and Top 10 Molecule Types, H2 2016 243

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports